Oscar Health (OSCR) Enrollment Exceeds Expectations in Health Insurance Exchanges
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 09 2026
0mins
Source: Yahoo Finance
- Optimistic Enrollment: Oscar Health's enrollment in health insurance exchanges is likely better than previously expected, indicating increased market appeal and customer demand, which could lay the groundwork for future revenue growth.
- Enhanced Market Competitiveness: With rising enrollment numbers, Oscar Health is poised to strengthen its market share in the highly competitive health insurance sector, thereby boosting brand recognition and customer loyalty.
- Improved Financial Outlook: Higher enrollment figures may enhance the company's financial performance, potentially driving stock price increases and attracting more investor attention, further strengthening its capital structure.
- Strategic Adjustment Necessity: To adapt to the evolving market demands, Oscar Health may need to adjust its strategies to ensure sustained growth and profitability, especially in the face of challenges from other competitors.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy OSCR?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on OSCR
Wall Street analysts forecast OSCR stock price to fall
8 Analyst Rating
1 Buy
4 Hold
3 Sell
Hold
Current: 23.600
Low
11.00
Averages
15.75
High
25.00
Current: 23.600
Low
11.00
Averages
15.75
High
25.00
About OSCR
Oscar Health, Inc. is a healthcare technology company built around a full stack technology platform. The Company's offerings include its insurance business and +Oscar Platform. Its health plans are offered in the individual market. The individual market primarily consists of policies purchased by individuals and families through health insurance marketplaces, established by the ACA and operated by the federal government, as well as other marketplaces operated by individual states. Individuals and families may also purchase policies in the individual market off-exchange. Employees whose employers have chosen to offer an Individual Coverage Health Reimbursement Arrangement (ICHRA) are also able to purchase its health plans. It offers health plans in the individual market under the five metal plan categories defined by the ACA: Catastrophic, Bronze, Silver, Gold, and Platinum. Through the +Oscar platform, the Company deploys its technology to help others throughout the healthcare system.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Oscar Health Shares Surge After Wells Fargo Upgrade
- Upgrade Impact: Wells Fargo upgraded Oscar Health from Underweight to Equal Weight, with analyst Stephen Baxter expressing increased confidence in the Affordable Care Act marketplace, leading to a stock price surge that indicates a more optimistic market outlook for the company.
- Improved Market Trends: Baxter noted that despite poor long-term visibility, better-than-expected enrollment and morbidity trends have bolstered his confidence in the 2026 ACA Marketplace forecasts, reflecting the company's proactive adjustments in pricing strategies.
- Strong Florida Performance: Florida, which accounts for approximately 64% of Oscar's premium revenue, has experienced only a 13.5% year-over-year decline in membership, alongside a 370bps year-over-year improvement in the medical loss ratio, showcasing the company's resilience and potential in this key market.
- Target Price Increase: The analyst raised the per-share target price for Oscar Health from $11 to $20, reflecting enhanced confidence in the company's future profitability, although he cautioned that uncertainty in the market is expected to remain high beyond 2026.
See More
Investment Comparison: Oscar Health vs. UnitedHealth
- Oscar Health Growth Potential: Oscar Health reported approximately $11.7 billion in revenue for FY 2025, reflecting a 27.5% increase with nearly 3.2 million members, despite a net loss of about $443.2 million, indicating both challenges and opportunities in a rapidly growing market.
- UnitedHealth Stability: UnitedHealth generated nearly $447.6 billion in revenue for FY 2025, an 11.8% increase, with a net income of approximately $12.1 billion and a net margin of 2.7%, showcasing its leadership through a vast customer base and diversified services.
- Risks and Challenges: Oscar Health faces significant risks from changes to the Affordable Care Act, particularly regarding federal funding and premium tax credits, while UnitedHealth must effectively manage medical costs and cybersecurity risks to maintain its market position and profitability.
- Valuation Comparison: Oscar Health has a forward P/E ratio of 25.8x, lower than UnitedHealth's 20.6x, while its P/S ratio stands at 0.5x, indicating relative undervaluation amidst high growth potential, prompting investors to weigh stability against growth opportunities.
See More
Investment Comparison: Oscar Health vs. UnitedHealth Group
- Revenue Growth Comparison: Oscar Health reported approximately $11.7 billion in revenue for FY 2025, reflecting a 27.5% increase despite a net loss of about $443.2 million, indicating its rapid expansion potential in the individual health insurance market.
- Market Scale and Risks: UnitedHealth Group achieved nearly $447.6 billion in revenue for FY 2025, an 11.8% increase, with its vast customer base and diversified revenue streams providing stability, yet it faces concentration risk from the Centers for Medicare & Medicaid Services.
- Financial Health Metrics: Oscar Health's debt-to-equity ratio stands at approximately 0.4, indicating a conservative leverage level, while UnitedHealth's ratio is around 0.8, suggesting a relative reliance on debt financing that may impact liquidity.
- Investor Choice Dilemma: Investors weighing Oscar Health against UnitedHealth must navigate the trade-off between stability and growth potential, as Oscar Health, being a newer entrant, presents higher risks but also the promise of greater returns through its innovative digital service model.
See More
Oscar Health: Potential in the Health Insurance Market
- Market Share Growth: Oscar Health's total paying members reached 3.2 million last quarter, reflecting over a 50% increase from 2 million a year ago, indicating significant market share gains in the ACA sector and positioning the company strongly in the rapidly growing health insurance market.
- Revenue Expectations Rise: Oscar Health is guiding for $19 billion in revenue at the high end for 2026, and if it can reach 10 million members, annual premiums could exceed $50 billion, presenting substantial revenue growth potential, especially amid rising healthcare costs.
- Technology-Driven Profitability: The company generated $700 million in operating income last quarter, with expectations of $250 million to $450 million in operating earnings for 2026, and as Oscar Health scales and improves technological efficiencies, its profitability is expected to significantly enhance in the coming years.
- Investor Confidence Boost: With a current market cap of $6.6 billion and a price-to-earnings ratio of 15 based on 2026 earnings guidance, Oscar Health demonstrates strong potential for profit growth over the next decade, attracting interest from long-term investors.
See More
Oscar Health's 53% Surge Still Underappreciated
- Market Share Growth: Oscar Health's paying insurance members reached 3.2 million by Q1 2026, a significant increase from just over 500,000 in Q1 2021, demonstrating strong performance in the ACA marketplace and enhancing the company's competitive edge in the health insurance sector.
- Operating Leverage Realized: In Q1 2026, Oscar Health generated $700 million in operating income, successfully increasing market share despite rising healthcare utilization, thanks to flexible pricing strategies and conservative utilization forecasts, with annual operating earnings expected to reach between $250 million and $450 million, marking a record high.
- Significant Profit Potential: With a market cap of $6.63 billion, Oscar Health remains undervalued despite a 53% stock price increase this year, especially when considering projected revenues of $19 billion and operating income of $450 million, indicating substantial long-term growth potential.
- Optimistic Industry Outlook: As the U.S. healthcare industry continues to expand, Oscar Health is poised to achieve over $30 billion in premium revenue, and with a 3% profit margin, this could translate to $900 million in annual operating income, further solidifying its market position.
See More
Oscar Health's Rapid Growth in Insurance Market
- Market Share Growth: Oscar Health has seen its membership surge to 3.2 million, a significant increase from just over 500,000 in Q1 2021, demonstrating strong performance in the ACA marketplace despite pressure from traditional competitors.
- Profitability Improvement: In Q1 2026, Oscar Health generated $700 million in operating income, marking a successful turnaround from a $400 million operating loss in 2025, showcasing the management's agile response to challenges.
- Optimistic Future Outlook: Although the company expects annual operating earnings to range between $250 million and $450 million in 2026, this would still represent a record high for the business, indicating potential for scaling and enhanced profitability.
- Attractive Valuation: With a current market cap of $6.63 billion and a 53% stock price increase this year, Oscar Health remains relatively undervalued compared to its potential future revenue of $19 billion and operating income of $450 million, reflecting its long-term growth prospects.
See More
Oscar Health Shares Surge After Wells Fargo Upgrade
- Upgrade Impact: Wells Fargo upgraded Oscar Health from Underweight to Equal Weight, with analyst Stephen Baxter expressing increased confidence in the Affordable Care Act marketplace, leading to a stock price surge that indicates a more optimistic market outlook for the company.
- Improved Market Trends: Baxter noted that despite poor long-term visibility, better-than-expected enrollment and morbidity trends have bolstered his confidence in the 2026 ACA Marketplace forecasts, reflecting the company's proactive adjustments in pricing strategies.
- Strong Florida Performance: Florida, which accounts for approximately 64% of Oscar's premium revenue, has experienced only a 13.5% year-over-year decline in membership, alongside a 370bps year-over-year improvement in the medical loss ratio, showcasing the company's resilience and potential in this key market.
- Target Price Increase: The analyst raised the per-share target price for Oscar Health from $11 to $20, reflecting enhanced confidence in the company's future profitability, although he cautioned that uncertainty in the market is expected to remain high beyond 2026.
See More
Investment Comparison: Oscar Health vs. UnitedHealth
- Oscar Health Growth Potential: Oscar Health reported approximately $11.7 billion in revenue for FY 2025, reflecting a 27.5% increase with nearly 3.2 million members, despite a net loss of about $443.2 million, indicating both challenges and opportunities in a rapidly growing market.
- UnitedHealth Stability: UnitedHealth generated nearly $447.6 billion in revenue for FY 2025, an 11.8% increase, with a net income of approximately $12.1 billion and a net margin of 2.7%, showcasing its leadership through a vast customer base and diversified services.
- Risks and Challenges: Oscar Health faces significant risks from changes to the Affordable Care Act, particularly regarding federal funding and premium tax credits, while UnitedHealth must effectively manage medical costs and cybersecurity risks to maintain its market position and profitability.
- Valuation Comparison: Oscar Health has a forward P/E ratio of 25.8x, lower than UnitedHealth's 20.6x, while its P/S ratio stands at 0.5x, indicating relative undervaluation amidst high growth potential, prompting investors to weigh stability against growth opportunities.
See More
Investment Comparison: Oscar Health vs. UnitedHealth Group
- Revenue Growth Comparison: Oscar Health reported approximately $11.7 billion in revenue for FY 2025, reflecting a 27.5% increase despite a net loss of about $443.2 million, indicating its rapid expansion potential in the individual health insurance market.
- Market Scale and Risks: UnitedHealth Group achieved nearly $447.6 billion in revenue for FY 2025, an 11.8% increase, with its vast customer base and diversified revenue streams providing stability, yet it faces concentration risk from the Centers for Medicare & Medicaid Services.
- Financial Health Metrics: Oscar Health's debt-to-equity ratio stands at approximately 0.4, indicating a conservative leverage level, while UnitedHealth's ratio is around 0.8, suggesting a relative reliance on debt financing that may impact liquidity.
- Investor Choice Dilemma: Investors weighing Oscar Health against UnitedHealth must navigate the trade-off between stability and growth potential, as Oscar Health, being a newer entrant, presents higher risks but also the promise of greater returns through its innovative digital service model.
See More
Oscar Health: Potential in the Health Insurance Market
- Market Share Growth: Oscar Health's total paying members reached 3.2 million last quarter, reflecting over a 50% increase from 2 million a year ago, indicating significant market share gains in the ACA sector and positioning the company strongly in the rapidly growing health insurance market.
- Revenue Expectations Rise: Oscar Health is guiding for $19 billion in revenue at the high end for 2026, and if it can reach 10 million members, annual premiums could exceed $50 billion, presenting substantial revenue growth potential, especially amid rising healthcare costs.
- Technology-Driven Profitability: The company generated $700 million in operating income last quarter, with expectations of $250 million to $450 million in operating earnings for 2026, and as Oscar Health scales and improves technological efficiencies, its profitability is expected to significantly enhance in the coming years.
- Investor Confidence Boost: With a current market cap of $6.6 billion and a price-to-earnings ratio of 15 based on 2026 earnings guidance, Oscar Health demonstrates strong potential for profit growth over the next decade, attracting interest from long-term investors.
See More
Oscar Health's 53% Surge Still Underappreciated
- Market Share Growth: Oscar Health's paying insurance members reached 3.2 million by Q1 2026, a significant increase from just over 500,000 in Q1 2021, demonstrating strong performance in the ACA marketplace and enhancing the company's competitive edge in the health insurance sector.
- Operating Leverage Realized: In Q1 2026, Oscar Health generated $700 million in operating income, successfully increasing market share despite rising healthcare utilization, thanks to flexible pricing strategies and conservative utilization forecasts, with annual operating earnings expected to reach between $250 million and $450 million, marking a record high.
- Significant Profit Potential: With a market cap of $6.63 billion, Oscar Health remains undervalued despite a 53% stock price increase this year, especially when considering projected revenues of $19 billion and operating income of $450 million, indicating substantial long-term growth potential.
- Optimistic Industry Outlook: As the U.S. healthcare industry continues to expand, Oscar Health is poised to achieve over $30 billion in premium revenue, and with a 3% profit margin, this could translate to $900 million in annual operating income, further solidifying its market position.
See More
Oscar Health's Rapid Growth in Insurance Market
- Market Share Growth: Oscar Health has seen its membership surge to 3.2 million, a significant increase from just over 500,000 in Q1 2021, demonstrating strong performance in the ACA marketplace despite pressure from traditional competitors.
- Profitability Improvement: In Q1 2026, Oscar Health generated $700 million in operating income, marking a successful turnaround from a $400 million operating loss in 2025, showcasing the management's agile response to challenges.
- Optimistic Future Outlook: Although the company expects annual operating earnings to range between $250 million and $450 million in 2026, this would still represent a record high for the business, indicating potential for scaling and enhanced profitability.
- Attractive Valuation: With a current market cap of $6.63 billion and a 53% stock price increase this year, Oscar Health remains relatively undervalued compared to its potential future revenue of $19 billion and operating income of $450 million, reflecting its long-term growth prospects.
See More
